Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 -23.88M
March 31, 2026 -6.748M
December 31, 2025 -4.473M
September 30, 2025 -10.66M
June 30, 2025 -6.02M
March 31, 2025 -9.987M
December 31, 2024 -7.562M
September 30, 2024 -10.49M
June 30, 2024 -12.79M
March 31, 2024 2.53M
December 31, 2023 -7.997M
September 30, 2023 -8.662M
June 30, 2023 -8.467M
March 31, 2023 -9.503M
December 31, 2022 -9.22M
September 30, 2022 -7.187M
June 30, 2022 -11.13M
March 31, 2022 -11.21M
December 31, 2021 -9.116M
September 30, 2021 -6.60M
June 30, 2021 -5.997M
March 31, 2021 -9.651M
December 31, 2020 -7.734M
Date Value
September 30, 2020 -8.643M
June 30, 2020 -9.315M
March 31, 2020 -5.522M
December 31, 2019 -5.73M
September 30, 2019 -6.132M
June 30, 2019 -3.44M
March 31, 2019 -3.842M
December 31, 2018 -4.212M
September 30, 2018 -2.79M
June 30, 2018 -6.043M
March 31, 2018 -3.928M
December 31, 2017 -3.383M
September 30, 2017 -2.349M
June 30, 2017 -2.147M
March 31, 2017 -4.358M
December 31, 2016 -5.662M
September 30, 2016 -2.107M
June 30, 2016 -2.613M
March 31, 2016 -3.04M
December 31, 2015 -1.772M
September 30, 2015 -2.002M
June 30, 2015 -2.658M
March 31, 2015 0.00

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
IQVIA Holdings, Inc. -381.00M
Charles River Laboratories International, Inc. 28.10M
Avantor, Inc. -37.30M
Champions Oncology, Inc. -0.055M
Personalis, Inc. 38.16M